AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 2, 1998, Pages 235-241

  Chiarantini, Laura ^b   Matteucci, Donatella ^a   Pistello, Mauro ^a   Mancini, Umberto ^b   Mazzetti, Paola ^a   Massi, Claudia ^a   Giannecchini, Simone ^a   Lonetti, Isabella ^a   Magnani, Mauro ^b   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AVIDIN; BIOTIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; FELINE IMMUNODEFICIENCY VIRUS; FOLLOW UP; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; VACCINATION; VIRUS ISOLATION; VIRUS PURIFICATION;

EID: 0031900536     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.2.235-241.1998     Document Type: Article

References (41)

1. Arthur, L. O., J. W. Bess, Jr., R. C. Sowder II, R. E. Benveniste, D. L. Mann, J.-C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938.
2. Baldinotti, F., D. Matteucci, P. Mazzetti, C. Giannelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68:4572-4579.
3. Beatty, A. J., B. J. Willett, E. A. Gault, and O. Jarrett. 1996. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J. Virol. 70: 6199-6206.
4. Bendinelli, M., M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi, and F. Tozzini. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8:87-120.
5. Bishop, S. A., C. R. Stokes, T. J. Gruffydd-Jones, C. V. Whiting, J. E. Humphries, R. Osborne, M. Papanastasopoulou, and D. A. Harbour. 1996. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response. Vaccine 14:1243-1250.
6. Bolognesi, D. P. 1995. The dilemma of developing and testing AIDS vaccines, p. 301-312. In G. M. Cooper, R. G. Temin, and B. Sugden (ed.), The DNA provirus: Howard Temin's scientific legacy. American Society for Microbiology, Washington, D.C.
7. Cammarota, G., D. Matteucci, M. Pistello, E. Nicoletti, S. Giannecchini, and M. Bendinelli. 1996. Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in the V4 region of the surface glycoprotein. AIDS Res. Hum. Retroviruses 12:173-175.
8. Capobianchi, M. R., S. Fais, C. Castilletti, M. Gentile, F. Ameglio, P. Cordiali Fei, S. M. Santini, and F. Dianzani. 1994. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J. Infect. Dis. 169:886-889.
9. mac-32IP. AIDS 9:223-228.
10. Chiarantini, L., R. Argnani, S. Zucchini, L. Stevanata, P. Zabordi, M. P. Grossi, M. Magnani, and R. Manservigi. 1997. Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice. Vaccine 17:276-280.
11. Chiarantini, L., and M. Magnani. 1996. Immobilization of enzymes and proteins on red blood cells, p. 143-152. In G. F. Bekerstaff (ed.), Methods in molecular biotechnology, vol. 1. Humana Press, Totowa, N.J.
12. Dzaudu, J. K., M. E. Deh, D. L. Barratt, and G. E. Wise. 1984. Detection of erythrocyte membrane proteins, sialoglycoproteins, and lipids in the same polyacrylamide gel using a double-staining technique. Proc. Natl. Acad. Sci. USA 81:1733-1737.
13. Egberink, H. F., L. Keldermans, N. Schuurman. J. Stam, W. Hesselink, A. van Vliet, E. Verschoor, M. Horzinek, and A. de Ronde. 1994. Monoclonal antibodies to immunodominant and neutralizing domains of the envelope surface protein of feline immunodeficiency virus. J. Gen. Virol. 75:889-893.
14. Elder, J. H., and T. R. Phillips. 1995. Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. Adv. Virus Res. 45:225-247.
15. Giannecchini, S., D. Matteucci, P. Mazzetti, and M. Bendinelli. 1996. Incubation time for feline immunodeficiency virus cultures. J. Clin. Microbiol. 34:2036-2038.
16. Hilleman, M. R. 1995. Whether and when an AIDS vaccine? Nature Med. 1:1126-1129.
17. Hosie, M. J., T. H. Dunsford, A. de Ronde, B. J. Willett, C. A. Cannon, J. C. Neil, and O. Jarrett. 1996. Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine 14:405-411.
18. Hosie, M. J., and J. N. Flynn. 1996. Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. J. Virol. 70: 7561-7568.
19. Hosie, M. J., R. Osborne, J. K. Yamamoto, J. C. Neil, and O. Jarrett. 1995. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 69:1253-1255.
20. Hosie, M. J., and J. K. Yamamoto. 1995. Vaccination against FIV, p. 263-278. In B. Willett and O. Jarrett (ed.). Feline immunology and immunodeficiency. Oxford University Press. Oxford, England.
21. Lombardi, S., C. Garzelli, C. La Rosa, L. Zaccaro, S. Specter, G. Malvaldi, F. Tozzini, F. Esposito, and M. Bendinelli. 1993. Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J. Virol. 67:4742-4749.
22. Lombardi, S., C. Garzelli, M. Pistello, C. Massi, D. Matteucci, F. Baldinotti, G. Cammarota, L. Da Prato, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J. Virol. 68:8374-8379.
23. Lutz, H., R. Hofmann-Lehman, K. Bauer-Pham, E. Holznagel, F. Tozzini, M. Bendinelli, G. Reubel, A. Aubert, D. Davis, B. Cox, and E. Young. 1995. FIV vaccine studies. I. Immune response to recombinant FIV env genc products and outcome after challenge infection. Vet. Immunol. Immunopathol. 46: 103-113.
24. Magnani, M., L. Chiarantini, and U. Mancini. 1994. Preparation and characterization of biotinylated erythrocytes. Biotechnol. Appl. Biochem. 20: 335-345.
25. Magnani, M., L. Chiarantini, E. Vittoria, U. Mancini, L. Rossi, and A. Fazi. 1992. Red blood cells as an antigen-delivery system. Biotechnol. Appl. Biochem. 16:188-194.
26. Massi, C., S. Lombardi, E. Indino, D. Matteucci, C. La Rosa, F. Esposito, C. Garzelli, and M. Bendinelli. 1997. Most potential linear B-cell epitopes of Env glycoproteins of feline immunodeficiency virus are immunologically silent in mice. AIDS Res. Hum. Retroviruses 13:1121-1129.
27. Matteucci, D., M. Pistello, P. Mazzetti, S. Giannecchini, D. Del Mauro, I. Lonetti, L. Zaccaro, C. Pollera, S. Specter, and M. Bendinelli. 1997. Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted. J. Virol. 71:8368-8376.
28. Matteucci, D., M. Pistello, P. Mazzetti, S. Giannecchini, D. Del Mauro, L. Zaccaro, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1996. Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J. Virol. 70:617-622.
29. Moore, J., and A. Trkola. 1997. HIV type 1 coreceptors, neutralization serotypes, and vaccine development. AIDS Res. Hum. Retroviruses 13:733-736.
30. Moore, J. P., and D. D. Ho. 1995. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9:S117-S136.
31. Pedersen, N. C. 1993. Feline immunodeficiency virus infection, p. 191-228. In J. A. Levy (ed.), The retroviruses, vol. 2. Plenum Press, New York, N.Y.
32. Pistello, M., S. Menzo, M. Giorgi, L. Da Prato, G. Cammarota, M. Clementi, and M. Bendinelli. 1994. Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol. Cell. Probes 8:229-234.
33. Poignard, P., P. J. Klasse, and Q. J. Sattentau. 1996. Antibody neutralization of HIV-1. Immunol. Today 17:239-246.
34. Richardson, J., I. Fossati, A. Moraillon, S. Castelot, P. Sonigo, and G. Pancino. 1996. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope. J. Gen. Virol. 77:759-777.
35. Rigby, M. A., N. Mackay, G. Reid, R. Osborne, J. C. Neil, and O. Jarrett. 1996. Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. Vaccine 14:1095-1102.
36. Siebelink, K. H. J., W. Huisman, J. A. Karlas, G. F. Rimmelzwaan, M. L. Bosch, and A. D. M. E. Osterhaus. 1995, Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. J. Virol. 69:5124-5127.
37. Siebelink, K. H. J., E. Tijhaar, R. C. Huisman, W. Huisman, A. de Ronde, I. H. Darby, M. J. Francis, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 1995. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 69:3704-3711.
38. Stott, E. J. 1991. Anti-cell antibody in macaques. Nature 353:393.
39. Verschoor, E. J., M. J. Willemse, J. G. Stam, A. L. W. van Vliet, H. Pouwels, S. K. Chalmers, M. C. Horzinek, P. J. A. Sondermeijer, W. Hesselink, and A. de Ronde. 1996. Evaluation of subunit vaccines against feline immunodeficiency virus infection. Vaccine 14:285-289.
40. Willett, B. J., J. N. Flynn, and M. J. Hosie. 1997. FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today 18:182-189.
41. Yamamoto, J. K., T. Hohdatsu, R. A. Holmsted, R. Pu, H. Louie, H. A. Zochlinski, V. Acevedo, H. M. Johnson, G. A. Soulds, and M. B. Gardner. 1993. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 67:601-605.